"We Envision Growth Strategies Most Suited
to Your Business"

U.S. Home Infusion Therapy Market to Expand at 8.4% CAGR During 2023-2030; Economic and Clinical Benefits of Home Infusion Therapies to Drive Market Augmentation

May 22, 2023 | Healthcare

The U.S. home infusion therapy market size is anticipated to display robust growth by attaining USD 33.20 billion by 2030. Fortune Business Insights™ in its report titled “U.S. Home Infusion Therapy Market Size, Share & COVID-19 Impact Analysis, By Product (Devices, Drugs, and Services), By Indication (Enteral Nutrition, Anti-Infective, Chemotherapy, Hydration Therapy, Total Parenteral Nutrition, Immunoglobulins, and Others) and Forecast, 2023-2030” observes that the market size in 2022 stood at USD 17.26 billion and reached USD 18.82 billion in 2023. The market is projected to record a strong CAGR of 8.4% during 2023-2030. Growing incidences of chronic diseases, rising geriatric population, and high cost of hospital stays are the factors driving market expansion. Furthermore, a rise in the number of home infusion therapy options and infusion drugs available to patients will aid market proliferation in the upcoming years.

Collaboration Between Bio Compression Systems and InfuSystem Holdings Inc. to Provide Lymphedema Therapy to Elevate Market Proliferation

InfuSystem Holdings, Inc., a leading healthcare services provider, announced its decision to enter a joint agreement with Bio Compression Systems, Inc. Under this agreement, InfuSystem will also provide Lymphedema Therapy on its Integrated Therapy Service platform. InfuSystem’s turnkey solutions will also include providing pneumatic compression devices with non-calibrated and calibrated gradient pressure, garments, and certified technicians for proper fitting of the compression system.

Increasing Popularity of Home Infusion Therapy to Propel Market Proliferation Amid the Pandemic

The COVID-19 outbreak across the world resulted in the implantation of stringent lockdowns and social distancing norms in several economies. People were forced to stay at home to curb the rising number of cases which in turn elevated the number of people receiving home infusion therapy and aided market expansion. Moreover, infusion pumps were increasingly used to treat COIVID-19 patients especially after the emergency use authorization of these pumps for monoclonal antibody treatments by the FDA which contributed to market growth in the pandemic.

Economic and Clinical Benefits of Home Infusion Therapies to Drive Market Augmentation

Healthcare agencies and the government are making efforts to promote home infusion therapy and encourage its adoption among patients due to the growing economic burden of treatments in healthcare facilities and hospitals. Moreover, a shortage of physicians, beds and other resources has increased the number of patients preferring treatment in homecare settings which is driving U.S. home infusion therapy market growth. Furthermore, home therapies are more economical as they eliminate additional costs such as hospital inpatient stays, hospital visits, and examination charges which propel their adoption among patients.

On the other hand, concerns regarding the safety of home infusion therapies among patients and healthcare professionals is a key factor hindering market proliferation. Additionally, the absence of a physician in case of an adverse event or emergency will pose as a challenge hampering market growth.

To get a detailed report summary and research scope of this market, click here:


Growing Focus on Research and Development Activities to Launch Advanced Products to Aid Market Proliferation

Industry leaders in the market often take tactical or strategic decisions to improve profit margins, generate higher revenues, and enhance geographical reach. These decisions include partnerships, collaborations, mergers & acquisitions and product launches. In some cases, they participate in research and development activities and launch advanced products to meet rising demand from consumers. For example, in January 2021, OSU alumnus unveiled a new technology, IV Ensure, which is aimed at revolutionizing at-home infusion treatment. The device uses remote monitoring to help patients monitor their health and enhance compliance thus improving health outcomes.

Notable Industry Development

  • August 2022: Baxter International Inc. announced that it received U.S. Food and Drug Administration (FDA) approval for its next-generation Novum IQ syringe infusion pump (SYR) with Dose IQ Safety SoftwareThe Novum IQ SYR has the capacity to be integrated with hospital electronic medical records (EMRs) through Baxter’s IQ Enterprise Connectivity Suite. The Novum IQ SYR offers an enhanced user experience with improved safety features, better connectivity, configurable anesthesia care settings and a robust portfolio of sets designed to help deliver optimum accuracy.

List of Key Companies Profiled in the Report:

  • Option Care Health Inc. (U.S.)

  • Optum Inc. (U.S.)

  • CareCentrix Inc. (U.S.)

  •  CVS Health (U.S.)

  • KabaFusion (U.S.)

  • Promptcare Respiratory (U.S.)

  •  Baxter (U.S.)

  • InfuSystem Holdings, Inc. (U.S.)

  • Moog Inc. (U.S.)

Further Report Findings

  • As per product, the drugs segment held a significant U.S. home infusion therapy market share in 2022 and is slated to expand significantly in the forthcoming years. The growing prevalence of chronic diseases, increasing regulatory approvals for products, and high risk of infection in hospitals are the factors driving segment growth.

  • According to indication, the enteral nutrition segment dominated the market in 2022 owing to the increasing number of patients suffering from diabetes and gastrointestinal diseases who need enteral feeding.

  • Optum Inc. held a considerable market share in 2022. The introduction of advanced infusion services to increase the brand presence of the company, strong emphasis on partnerships and acquisitions with other major players to widen the portfolio and increase brand awareness are some factors that have strengthened the presence of the company.

Table of Segmentation



Study Period


Base Year


Estimated Year


Forecast Period


Historical Period


Growth Rate

CAGR of 8.4% from 2023 to 2030


Value (USD billion)


By Product, Indication

By Product

  • Devices

  • Drugs

  • Services

By Indication

  • Anti-Infective

  • Chemotherapy

  • Hydration Therapy

  • Enteral Nutrition

  • Total Parenteral Nutrition

  • Immunoglobulins

  • Others

U.S. Home Infusion Therapy Market
  • PDF
  • 2022
  • 2019-2021
  • 80


  • 2850

Our Clients

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.